Bruker EVP Munch exercises options, sells 2,000 shares
Mark Munch, an executive vice president of Bruker Corp, exercised stock options for 2,000 shares at $22.19 per share and sold 2,000 common shares at $60.25 per share in open-market trades under a Rule 10b5-1 trading plan.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Mark Munch, an executive vice president of Bruker Corp, exercised stock options for 2,000 shares at $22.19 per share and sold 2,000 common shares at $60.25 per share in open-market trades under a Rule 10b5-1 trading plan. After these transactions he holds 128,443 common shares directly and 4,000 stock options exercisable at $22.19 expiring on October 4, 2026.
Insider Trade Summary
Exercise and Sale: 2,000 shares ($76K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Munch Mark
Role
EXEC VP&PRES BRUKER NANO INC.
Sold
2,000 shs ($121K)
Approx. gross sale proceeds
$121K
Approx. exercise cost
$44K
Approx. pre-tax spread
$76K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Purchase) F2 | 2,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,000 | $22.19 | $44K |
| Sale | Common Stock F1 | 2,000 | $60.25 | $121K |
Holdings After Transaction:
Stock Option (Right to Purchase) — 4,000 contracts (Direct);
Common Stock — 128,443 shares (Direct)
Footnotes (2)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2. The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests on the first, second, third and fourth anniversaries of the Original Grant Date.
Key Figures
Shares sold: 2,000 shares
Sale price: $60.25 per share
Shares acquired via option exercise: 2,000 shares
+3 more
6 metrics
Shares sold
2,000 shares
Open-market sale of Bruker Corp common stock on July 15, 2026
Sale price
$60.25 per share
Price received for 2,000 Bruker Corp common shares sold
Shares acquired via option exercise
2,000 shares
Common shares obtained by exercising stock options on July 15, 2026
Option exercise price
$22.19 per share
Exercise price for stock options converted into 2,000 common shares
Shares held after transactions
128,443 shares
Direct Bruker Corp common share holdings following reported trades
Options held after exercise
4,000 options
Remaining stock options with $22.19 exercise price expiring October 4, 2026
Key Terms
Rule 10b5-1 trading plan, Stock Option (Right to Purchase), derivative security, open-market sale
4 terms
Rule 10b5-1 trading plan regulatory
"The sales were effected pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (Right to Purchase) financial
"Security title listed as Stock Option (Right to Purchase) with 2,000 shares"
derivative security financial
"Transaction code M described as Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open-market sale financial
"Transaction action identified as open-market sale of common stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Mark Munch report for BRKR?
Mark Munch reported exercising stock options for 2,000 Bruker Corp shares at $22.19 and selling 2,000 common shares at $60.25. Both transactions occurred on July 15, 2026 and were recorded as direct holdings changes.
What stock options did Mark Munch exercise in this BRKR Form 4?
He exercised stock options covering 2,000 Bruker Corp shares at an exercise price of $22.19 per share. These options are part of a grant dated October 4, 2016 that vests over four years from that original grant date.
How many Bruker Corp options does Mark Munch still hold and when do they expire?
After the reported exercise, Mark Munch holds 4,000 Bruker Corp stock options with an exercise price of $22.19. These options are scheduled to expire on October 4, 2026, consistent with the original 2016 option grant terms.
Were Mark Munch’s BRKR stock sales made under a Rule 10b5-1 plan?
Yes. The reported sales of 2,000 Bruker Corp shares were effected under a Rule 10b5-1 trading plan adopted by Mark Munch. Such plans pre-schedule trades, reducing the significance of trade timing as an indicator of insider sentiment.
AI-generated analysis. How Rhea-AI works. Not financial advice.
